Edap Tms S.A. (NASDAQ:EDAP – Get Rating) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 43,400 shares, an increase of 101.9% from the April 30th total of 21,500 shares. Based on an average daily trading volume, of 58,200 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.1% of the company’s shares are short sold.
A number of large investors have recently modified their holdings of EDAP. Morgan Stanley lifted its stake in Edap Tms by 92.2% during the 3rd quarter. Morgan Stanley now owns 1,497,285 shares of the medical equipment provider’s stock valued at $9,553,000 after acquiring an additional 718,460 shares in the last quarter. Soleus Capital Management L.P. raised its stake in shares of Edap Tms by 6.5% during the 4th quarter. Soleus Capital Management L.P. now owns 3,148,609 shares of the medical equipment provider’s stock worth $18,860,000 after purchasing an additional 192,242 shares during the period. Allspring Global Investments Holdings LLC bought a new stake in shares of Edap Tms during the 1st quarter worth $723,000. Rock Springs Capital Management LP raised its stake in shares of Edap Tms by 7.8% during the 1st quarter. Rock Springs Capital Management LP now owns 820,000 shares of the medical equipment provider’s stock worth $5,945,000 after purchasing an additional 59,100 shares during the period. Finally, Bank of America Corp DE raised its stake in shares of Edap Tms by 403.4% during the 2nd quarter. Bank of America Corp DE now owns 42,959 shares of the medical equipment provider’s stock worth $304,000 after purchasing an additional 34,426 shares during the period. Institutional investors and hedge funds own 28.71% of the company’s stock.
Several research firms recently issued reports on EDAP. Zacks Investment Research raised shares of Edap Tms from a “sell” rating to a “hold” rating in a research report on Monday, May 16th. Piper Sandler reduced their price target on shares of Edap Tms from $13.00 to $11.00 in a research report on Wednesday, May 18th. Finally, StockNews.com began coverage on shares of Edap Tms in a research report on Thursday, March 31st. They issued a “hold” rating for the company.
Edap Tms (NASDAQ:EDAP – Get Rating) last issued its quarterly earnings data on Tuesday, May 17th. The medical equipment provider reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.02. Edap Tms had a return on equity of 0.44% and a net margin of 0.47%. The business had revenue of $14.53 million for the quarter, compared to analysts’ expectations of $12.96 million. During the same period last year, the business earned $0.03 EPS. As a group, equities research analysts expect that Edap Tms will post -0.08 EPS for the current year.
About Edap Tms (Get Rating)
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).
- Get a free copy of the StockNews.com research report on Edap Tms (EDAP)
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
- Is RBC Bearings Rolling Into A Reversal?
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.